Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion type Assertion NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_head.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion description "[To determine whether increased levels of sialyl Lewis X leads to malignancy in prostate tumor, we transfected the human prostate cancer cell line PC-3 with alpha1,3-fucosyltransferase III (FTIII) to obtain stable transfectants, PC-3-FTIII lines, that highly express sialyl Lewis X.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion evidence source_evidence_literature NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion SIO_000772 14601054 NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion wasDerivedFrom befree-20140225 NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.
- NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_assertion wasGeneratedBy ECO_0000203 NP877919.RAg7YBC4T7k63Ls0QrFDo5-FflrCrIJknFNdZx7d3rQIE130_provenance.